rs1296826867
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_152383.5(DIS3L2):c.1703A>G(p.Gln568Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000274 in 1,461,644 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_152383.5 missense
Scores
Clinical Significance
Conservation
Publications
- Perlman syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DIS3L2 | NM_152383.5 | c.1703A>G | p.Gln568Arg | missense_variant | Exon 14 of 21 | ENST00000325385.12 | NP_689596.4 | |
DIS3L2 | NR_046476.2 | n.1849A>G | non_coding_transcript_exon_variant | Exon 14 of 21 | ||||
DIS3L2 | NR_046477.2 | n.1825A>G | non_coding_transcript_exon_variant | Exon 13 of 19 | ||||
DIS3L2 | NM_001257281.2 | c.1581+36721A>G | intron_variant | Intron 13 of 13 | NP_001244210.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000402 AC: 1AN: 249052 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461644Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 727110 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Perlman syndrome Uncertain:2
This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 568 of the DIS3L2 protein (p.Gln568Arg). This variant is present in population databases (no rsID available, gnomAD no frequency). This variant has not been reported in the literature in individuals affected with DIS3L2-related conditions. ClinVar contains an entry for this variant (Variation ID: 463067). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt DIS3L2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Inborn genetic diseases Uncertain:1
The c.1703A>G (p.Q568R) alteration is located in exon 14 (coding exon 13) of the DIS3L2 gene. This alteration results from a A to G substitution at nucleotide position 1703, causing the glutamine (Q) at amino acid position 568 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at